Salvatore Ribisi

Personalized therapeutic strategies in HER2-driven gastric cancer

A. Sapino, S. Bellomo, P. Cassoni, 2021, Gastric Cancer.

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

P. Provero, A. Sapino, S. Bellomo, 2020, ESMO Open.